ABT

NYSE Abbott Laboratories

Oct 2, 2026 · 6:47 PM ET LAST TRADE Market Closed

$97.15 ↓ -0.35 (-0.36%) Trading Down from the previous close of $97.50, $0.44 below the day’s high of $97.59

YTD change: -22.46%
vs 20-day SMA: -5.47%
vs 200-day SMA: -6.74%

Price ranges

Previous day

$96.54 $99.45

open $99.24 close $96.69

-$2.55 (-2.57%)

Today

$95.06 $97.59

open $96.50 now $97.15

+$0.65 (+0.67%)

Past week

$96.54 $101.82

from $101.07 now $97.15

-$3.92 (-3.88%)

Past month

$96.54 $112.00

from $110.47 now $97.15

-$13.32 (-12.06%)

This year

$81.97 $129.46

from $125.29 now $97.15

-$28.14 (-22.46%)

Price & Performance

-6.18 (-6.01%) / 6M

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Poor

The stock is 31.9% away from all-time highs of $142.60
ABT is down 22% since the beginning of the year
ABT is down 27% over the past 12 months
ABT is down 12% over the past 1 month
1% of all ABT investors are betting against ABT
Number of investors short ABT has gone down 10% versus last month

ABT reads poor: price sits below both the 20- and 200-day averages, short interest is falling month over month, the 12-month move is -27.3%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable Yes

EPS $1.31

Earnings momentum +7.7% Quarterly EPS growth

Quarterly change +7.7%

Valuation

P/E ratio 31.88

Enterprise value $196.2B

Beta 0.33

Balance sheet & scale

Income$5.4M

Revenue$46.6B

Cash$5.6B

Debt$32.6M

Income / Debt 0.17×

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNYSE

Sector Manufacturing

Sub Sector Computer and Electronic Product Manufacturing

Market cap $168.1B

Abbott Laboratories engages in the discovery, development, manufacture, and sale of healthcare products. It operates through the following segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment focuses on branded generic pharmaceuticals that are manufactured worldwide and marketed and sold outside the United States, primarily in emerging markets. The Diagnostic Products segment markets diagnostic systems and tests for blood banks, hospitals, commercial laboratories, clinics, physicians' offices, retailers, government agencies, and alternative care testing sites. The Nutritional Products segment oversees the worldwide sale of pediatric and adult nutritional products. The Medical Devices segment offers a broad range of rhythm management, electrophysiology, heart failure, vascular and structural heart devices for the treatment of cardiovascular diseases, as well as diabetes care and continuous glucose monitoring products. It also provides neuromodulation devices for the management of chronic pain and movement disorders. The company was founded by Wallace Calvin Abbott in 1888 and is headquartered in Abbott Park, IL.

Competitor comparison

Ticker	Company	Price	Change
TMO	Thermo Fisher Scientific Inc.	$652.51	-3.34%
ISRG	Intuitive Surgical, Inc.	$401.24	-1.33%
MDT	Medtronic Plc	$86.44	+0.17%
BSX	Boston Scientific Corporation	$43.23	-0.96%
EW	Edwards Lifesciences Corporation	$85.19	-1.31%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.